Recent Study Explores Cyclin Dependent Kinase 9 Market Pipeline Review, H2 2017
Overview
Cyclin Dependent Kinase 9 (Tat Associated Kinase Complex Catalytic Subunit or C 2K or Cell Division Cycle 2 Like Protein Kinase 4 or Cell Division Protein Kinase 9 or Serine/Threonine Protein Kinase PITALR or CDK9 or EC 2.7.11.22 or EC 2.7.11.23) - Cyclin-dependent kinase 9 (CDK9) is a cyclin-dependent kinase associated with P-TEFb.
This kinase was found to be a component of the multiprotein complex TAK/P-TEFb, which is an elongation factor for RNA polymerase II-directed transcription and functions by phosphorylating the C-terminal domain of the largest subunit of RNA polymerase II. This protein forms a complex with and is regulated by its regulatory subunit cyclin T or cyclin K. HIV-1 Tat protein was found to interact with CDK9 and cyclin T, which suggested a possible involvement of this protein in AIDS.
Click here for sample report @ https://www.wiseguyreports.com/sample-request/619226-cyclin-dependent-kinase-9-11-23-pipeli
Top Companies mentioned
AstraZeneca Plc
Bayer AG
Cyclacel Pharmaceuticals Inc
Eli Lilly and Co
Jyant Technologies Inc
MEI Pharma Inc
Selvita SA
Tolero Pharmaceuticals Inc
Vichem Chemie Research Ltd
Cyclin Dependent Kinase 9 Industry Major Outlook
Pharmaceutical and Healthcare latest pipeline guide Cyclin Dependent Kinase 9 - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Cyclin Dependent Kinase 9 , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Cyclin Dependent Kinase 9 (Tat Associated Kinase Complex Catalytic Subunit or C 2K or Cell Division Cycle 2 Like Protein Kinase 4 or Cell Division Protein Kinase 9 or Serine/Threonine Protein Kinase PITALR or CDK9 or EC 2.7.11.22 or EC 2.7.11.23) pipeline Target constitutes close to 26 molecules. Out of which approximately 22 molecules are developed by companies and remaining by the universities/institutes. The molecules developed by companies in Phase II, Phase I and Preclinical stages are 6, 4 and 12 respectively.
Cyclin Dependent Kinase 9 pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Cyclin Dependent Kinase 9 - Competitive Analysis
Key players are making innovative developments in Cyclin Dependent Kinase 9 industry. The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector
Scope
The pipeline guide provides a snapshot of the global therapeutic landscape of Cyclin Dependent Kinase 9.
The pipeline guide reviews pipeline therapeutics for Cyclin Dependent Kinase 9 by companies and universities/research institutes based on information derived from company and industry-specific sources.
The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
The pipeline guide reviews key companies involved in Cyclin Dependent Kinase 9 therapeutics and enlists all their major and minor projects.
The pipeline guide evaluates Cyclin Dependent Kinase 9 therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
The pipeline guide reviews latest news related to pipeline therapeutics for Cyclin Dependent Kinase 9.
.Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/619226-cyclin-dependent-kinase-9-11-23-pipeli
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK
Posted by
Vivian Dsena
on Wednesday February 21 2018, 2:30 AM EST.
All trademarks acknowledged.
Filed under Uncategorized.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
